Published in Mol Autism on November 15, 2013
Molecular underpinnings of prefrontal cortex development in rodents provide insights into the etiology of neurodevelopmental disorders. Mol Psychiatry (2014) 0.87
Convergence of Sex Differences and the Neuroimmune System in Autism Spectrum Disorder. Biol Psychiatry (2016) 0.83
Striatal-enriched protein tyrosine phosphatase regulates the PTPα/Fyn signaling pathway. J Neurochem (2015) 0.82
Inhibition of the tyrosine phosphatase STEP61 restores BDNF expression and reverses motor and cognitive deficits in phencyclidine-treated mice. Cell Mol Life Sci (2015) 0.80
Abnormalities in the zinc-metalloprotease-BDNF axis may contribute to megalencephaly and cortical hyperconnectivity in young autism spectrum disorder patients. Mol Brain (2014) 0.79
Applications of chemogenomic library screening in drug discovery. Nat Rev Drug Discov (2017) 0.79
Integrative proteomic analysis of the NMDA NR1 knockdown mouse model reveals effects on central and peripheral pathways associated with schizophrenia and autism spectrum disorders. Mol Autism (2014) 0.78
System-based proteomic and metabonomic analysis of the Df(16)A(+/-) mouse identifies potential miR-185 targets and molecular pathway alterations. Mol Psychiatry (2016) 0.77
Network organization is globally atypical in autism: A graph theory study of intrinsic functional connectivity. Biol Psychiatry Cogn Neurosci Neuroimaging (2017) 0.76
Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders. Cell Syst (2015) 0.76
Dysregulation of Alternative Poly-adenylation as a Potential Player in Autism Spectrum Disorder. Front Mol Neurosci (2017) 0.75
Dendritic overgrowth and elevated ERK signaling during neonatal development in a mouse model of autism. PLoS One (2017) 0.75
Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76
Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol (2004) 101.91
Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics (2003) 100.88
Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet (2008) 15.51
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet (2003) 15.31
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature (2012) 14.76
Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature (2012) 13.71
De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature (2012) 13.61
Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet (2006) 11.14
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science (2003) 8.81
Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science (2003) 8.48
Molecular signatures database (MSigDB) 3.0. Bioinformatics (2011) 8.08
Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ (2009) 7.02
A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann Neurol (1983) 6.80
Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet (2001) 5.91
A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet (2008) 5.28
A genome-wide linkage and association scan reveals novel loci for autism. Nature (2009) 4.76
Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science (2006) 4.68
PTEN loss in the continuum of common cancers, rare syndromes and mouse models. Nat Rev Cancer (2011) 4.37
Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet (2005) 4.14
Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron (2008) 3.65
A synaptic trek to autism. Curr Opin Neurobiol (2009) 3.53
Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs). RNA (2004) 3.16
Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron (2002) 2.93
Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One (2010) 2.67
The neurobiology of autism. Brain Pathol (2007) 2.63
Autistic behavior in children with fragile X syndrome: prevalence, stability, and the impact of FMRP. Am J Med Genet A (2006) 2.61
Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am J Hum Genet (2013) 2.47
A public health collaboration for the surveillance of autism spectrum disorders. Paediatr Perinat Epidemiol (2007) 2.36
Mood stabilizer valproate promotes ERK pathway-dependent cortical neuronal growth and neurogenesis. J Neurosci (2004) 2.17
Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet (2010) 2.14
Decoding NMDA receptor signaling: identification of genomic programs specifying neuronal survival and death. Neuron (2007) 2.08
Protein interactome reveals converging molecular pathways among autism disorders. Sci Transl Med (2011) 2.04
Purification and properties of extracellular signal-regulated kinase 1, an insulin-stimulated microtubule-associated protein 2 kinase. Biochemistry (1991) 2.01
Transcriptional neoteny in the human brain. Proc Natl Acad Sci U S A (2009) 1.78
The genetic landscapes of autism spectrum disorders. Annu Rev Genomics Hum Genet (2013) 1.77
Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev (2009) 1.71
The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders. Neuron (2012) 1.71
Intracellular control of developmental and regenerative axon growth. Philos Trans R Soc Lond B Biol Sci (2006) 1.70
Phosphatase and tensin homolog, deleted on chromosome 10 deficiency in brain causes defects in synaptic structure, transmission and plasticity, and myelination abnormalities. Neuroscience (2007) 1.59
Pten knockdown in vivo increases excitatory drive onto dentate granule cells. J Neurosci (2011) 1.51
Causal reasoning on biological networks: interpreting transcriptional changes. Bioinformatics (2012) 1.51
SFARI Gene: an evolving database for the autism research community. Dis Model Mech (2010) 1.50
Specific functions for ERK/MAPK signaling during PNS development. Neuron (2011) 1.45
Signaling mechanisms underlying reversible, activity-dependent dendrite formation. Neuron (2002) 1.45
Childhood autism and associated comorbidities. Brain Dev (2006) 1.38
Cellular toxicity following application of adeno-associated viral vector-mediated RNA interference in the nervous system. BMC Neurosci (2010) 1.33
Embryonic MAP2 lacks the cross-linking sidearm sequences and dendritic targeting signal of adult MAP2. Nature (1989) 1.26
The genetic variability and commonality of neurodevelopmental disease. Am J Med Genet C Semin Med Genet (2012) 1.23
Copy number variation modifies expression time courses. Genome Res (2010) 1.15
Enhanced CREB and DARPP-32 phosphorylation in the nucleus accumbens and CREB, ERK, and GluR1 phosphorylation in the dorsal hippocampus is associated with cocaine-conditioned place preference behavior. J Neurochem (2008) 1.08
Decreased exploratory activity in a mouse model of 15q duplication syndrome; implications for disturbance of serotonin signaling. PLoS One (2010) 1.05
Association of the polymorphisms in the 5'-untranslated region of PTEN gene with type 2 diabetes in a Japanese population. FEBS Lett (2003) 1.02
Fetal exposure to teratogens: evidence of genes involved in autism. Neurosci Biobehav Rev (2010) 1.02
Network activity-independent coordinated gene expression program for synapse assembly. Proc Natl Acad Sci U S A (2007) 0.94
Phosphatase and tensin homolog (PTEN) gene mutations and autism: literature review and a case report of a patient with Cowden syndrome, autistic disorder, and epilepsy. J Child Neurol (2011) 0.93
Dendritic spine plasticity: new regulatory roles of dynamic microtubules. Neuroscientist (2010) 0.93
Autism spectrum disorders: a pediatric overview and update. Curr Opin Pediatr (2013) 0.88
Autism and developmental abnormalities in children with perinatal cocaine exposure. J Natl Med Assoc (1992) 0.88
In vitro phosphorylation of microtubule-associated protein 2: differential effects of cyclic AMP analogues. J Neurochem (1985) 0.87
Retracted Association of upregulated Ras/Raf/ERK1/2 signaling with autism. Genes Brain Behav (2011) 0.87
Context-specific modulation of cocaine-induced locomotor sensitization and ERK and CREB phosphorylation in the rat nucleus accumbens. Eur J Neurosci (2009) 0.87
Chronic cocaine self-administration modulates ERK1/2 and CREB responses to dopamine receptor agonists in striatal slices. Addict Biol (2011) 0.83
Retracted Upregulation of Ras/Raf/ERK1/2 signaling and ERK5 in the brain of autistic subjects. Genes Brain Behav (2011) 0.83
Modeling the mechanism of action of a DGAT1 inhibitor using a causal reasoning platform. PLoS One (2011) 0.82
The ongoing dissection of the genetic architecture of autistic spectrum disorder. Mol Autism (2011) 0.82
GenSensor Suite: A Web-Based Tool for the Analysis of Gene and Protein Interactions, Pathways, and Regulation. Adv Bioinformatics (2011) 0.81
Role of the PACAP-PAC1-DISC1 and PACAP-PAC1-stathmin1 systems in schizophrenia and bipolar disorder: novel treatment mechanisms? Pharmacogenomics (2009) 0.81
Mining and modeling human genetics for autism therapeutics. Curr Opin Neurobiol (2012) 0.78
The small ubiquitin-like modifier (SUMO) protein modification system in Arabidopsis. Accumulation of SUMO1 and -2 conjugates is increased by stress. J Biol Chem (2002) 2.88
Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species. J Histochem Cytochem (2006) 1.60
MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function. Proc Natl Acad Sci U S A (2012) 1.49
Kinetic analysis of genomewide gene expression reveals molecule circuitries that control T cell activation and Th1/2 differentiation. Proc Natl Acad Sci U S A (2004) 1.10
The role of hypoxia in 2-butoxyethanol-induced hemangiosarcoma. Toxicol Sci (2009) 1.03
Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease. J Pharmacol Exp Ther (2010) 1.00
Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo. J Pharmacol Exp Ther (2012) 0.96
Identification of tubular injury microRNA biomarkers in urine: comparison of next-generation sequencing and qPCR-based profiling platforms. BMC Genomics (2014) 0.91
Phosphodiesterase 5A inhibitors improve functional recovery after stroke in rats: optimized dosing regimen with implications for mechanism. J Pharmacol Exp Ther (2009) 0.88
Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease. J Mol Biol (2011) 0.88
High throughput object-based image analysis of β-amyloid plaques in human and transgenic mouse brain. J Neurosci Methods (2011) 0.84
Molecular characterization of novel and selective peroxisome proliferator-activated receptor alpha agonists with robust hypolipidemic activity in vivo. Mol Pharmacol (2008) 0.83
Comparing 2-nt 3' overhangs against blunt-ended siRNAs: a systems biology based study. BMC Genomics (2009) 0.82
Heteroatom-linked indanylpyrazines are corticotropin releasing factor type-1 receptor antagonists. Bioorg Med Chem Lett (2007) 0.80
Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014. Bioorg Med Chem Lett (2010) 0.80
6-Alkoxyisoindolin-1-one based dopamine D2 partial agonists as potential antipsychotics. Bioorg Med Chem Lett (2010) 0.78
Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors. Naunyn Schmiedebergs Arch Pharmacol (2008) 0.77
Assessing the translatability of in vivo cardiotoxicity mechanisms to in vitro models using causal reasoning. BMC Pharmacol Toxicol (2013) 0.77
A non-brain penetrant PDE5A inhibitor improves functional recovery after stroke in rats. Restor Neurol Neurosci (2012) 0.76
Killing pain, not neurons. Nat Med (2005) 0.75
Diamide amino-imidazoles: a novel series of γ-secretase inhibitors for the treatment of Alzheimer's disease. Bioorg Med Chem Lett (2010) 0.75
CRF ligands via Suzuki and Negishi couplings of 3-pyridyl boronic acids or halides with 2-benzyloxy-4-chloro-3-nitropyridine. Bioorg Med Chem Lett (2003) 0.75
Imidazo[4,5-c]pyridines as corticotropin releasing factor receptor ligands. Bioorg Med Chem Lett (2003) 0.75
2,3,4,5-tetrahydro- and 2,3,4,5,11,11a-hexahydro-1H-[1,4]diazepino[1,7-a]indoles: new templates for 5-HT(2C) agonists. Bioorg Med Chem Lett (2003) 0.75
Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligands. Bioorg Med Chem Lett (2003) 0.75